An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV

NCT00027365 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: Combination Vaccine (NefTat and gp120W61D) Formulated with AS02A
BIOLOGICAL: NefTat
DRUG: AS02A Adjuvant
BIOLOGICAL: gp120W61D

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)